Urologix, Inc. Receives FDA Approval for T3Targeted Transurethral Thermoablation System Model 4000

Summary

The FDA has approved Urologix, Inc.'s application for premarket approval of the T3Targeted Transurethral Thermoablation System Model 4000, following a notification from the FDA's Center for Devices and Radiological Health on August 22, 1997.